Healthcare • Diagnostics & Research
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CDNA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
33 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 69 days ago
Red flags: 3
228 filers reported a long position in CDNA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $137.2M | 4.8M | +6.5% |
| STATE STREET CORP | $70.4M | 2.5M | -10.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $62.6M | 2.2M | +1.7% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $56.9M | 2M | -8.8% |
| ARK Investment Management LLC | $55.7M | 2M | -12.3% |
| Boston Partners | $55.2M | 1.9M | +2.9% |
| BAMCO INC /NY/ | $55.2M | 1.9M | -41.9% |
| GAGNON SECURITIES LLC | $50.5M | 1.8M | +0.5% |
| Chevy Chase Trust Holdings, LLC | $41M | 1.4M | -4.4% |
| GEODE CAPITAL MANAGEMENT, LLC | $37.9M | 1.3M | +5.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.